Mark Kronenfeld - Director, Pacira Biosciences, Inc

As of June 11, 2021


Mark Kronenfeld Net Worth

  • Net worth is estimated to be at least $954.31K
  • Owns at least 10,277 units of Pacira Biosciences, Inc stock
  • Sold an estimated value of $42.26K in the last 8 years at Pacira Biosciences, Inc

Mark Kronenfeld Trading

  • Largest purchase of shares was 850 units , worth over $76.91K on November 4, 2014
  • Largest sale of shares was 900 units , worth over $42.26K on June 8, 2016
  • In total has made about 15 transactions over 8 years
  • Usually trades in June, with the busiest year in 2014, 2019, 2018, 2013, 2016 and 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Mark Kronenfeld Mailing Address

  • Mailing address is C/o Pacira Pharmaceuticals, Inc. 5 Sylvan Way, Suite 100 Parsippany NJ 07054 NJ

Pacira Biosciences, Inc Insider Trading

  • The most recent transaction was 2,500 units sold on July 30, 2021 by Bullaro Lauren Riker worth over $152.12K
  • In the last 9 years, insiders at Pacira Biosciences, Inc sold an estimated value of $392.63M and bought an estimated value of $112.66M
  • The most active traders are David Stack, CEO and Chairman,  Andreas Wicki, Director,  and Bullaro Lauren Riker, Vice President
  • Insider trading is most common in June, with the busiest year in 2013

Pacira BioSciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1